Average Co-Inventor Count = 7.72
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (15 from 3,684 patents)
2. Rigel Pharmaceuticals, Incorporated (3 from 488 patents)
3. Bayer Corporation (1 from 1,008 patents)
4. Bayer Pharmaceuticals Corporation (1 from 70 patents)
5. Bristol Meyers Squibb Company (1 from 41 patents)
18 patents:
1. 11352360 - TGF-beta inhibitors
2. 10961239 - TGF beta receptor antagonists
3. 10287295 - TGF-β inhibitors
4. 9884868 - TGF-beta inhibitors
5. 9598423 - Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
6. 9556179 - Substituted imidazoles as casein kinase 1 D/E inhibitors
7. 9475817 - Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
8. 9273058 - Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
9. 9242967 - Substituted bicyclic heteroaryl compounds
10. 9145419 - Imidazopyridazinyl compounds
11. 8592579 - Pyrrolotriazine kinase inhibitors
12. 8415340 - Triazine kinase inhibitors
13. 7879855 - Pyrrolotriazine kinase inhibitors
14. 7534792 - Pyrrolotriazine kinase inhibitors
15. 7223757 - Tyrosine kinase inhibitors